BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19880059)

  • 1. Delivering consensus from the Asian Oncology Summit 2009.
    Collingridge D
    Lancet Oncol; 2009 Nov; 10(11):1029-30. PubMed ID: 19880059
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
    Wong NS; Anderson BO; Khoo KS; Ang PT; Yip CH; Lu YS; Voravud N; Shao ZM; Pritchard KI;
    Lancet Oncol; 2009 Nov; 10(11):1077-85. PubMed ID: 19880061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
    Kwong YL; Anderson BO; Advani R; Kim WS; Levine AM; Lim ST;
    Lancet Oncol; 2009 Nov; 10(11):1093-101. PubMed ID: 19880063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
    Soo RA; Anderson BO; Cho BC; Yang CH; Liao M; Lim WT; Goldstraw P; Mok TS;
    Lancet Oncol; 2009 Nov; 10(11):1102-10. PubMed ID: 19880064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.
    Wee JT; Anderson BO; Corry J; D'Cruz A; Soo KC; Qian CN; Chua DT; Hicks RJ; Goh CH; Khoo JB; Ong SC; Forastiere AA; Chan AT;
    Lancet Oncol; 2009 Nov; 10(11):1086-92. PubMed ID: 19880062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.
    Poon D; Anderson BO; Chen LT; Tanaka K; Lau WY; Van Cutsem E; Singh H; Chow WC; Ooi LL; Chow P; Khin MW; Koo WH;
    Lancet Oncol; 2009 Nov; 10(11):1111-8. PubMed ID: 19880065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
    Tangjitgamol S; Anderson BO; See HT; Lertbutsayanukul C; Sirisabya N; Manchana T; Ilancheran A; Lee KM; Lim SE; Chia YN; Domingo E; Kim YT; Lai CH; Dali AZ; Supakapongkul W; Wilailak S; Tay EH; Kavanagh J;
    Lancet Oncol; 2009 Nov; 10(11):1119-27. PubMed ID: 19880066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group.
    Mostert S; Arora RS; Arreola M; Bagai P; Friedrich P; Gupta S; Kaur G; Koodiyedath B; Kulkarni K; Lam CG; Luna-Fineman S; Pizer B; Rivas S; Rossell N; Sitaresmi MN; Tsimicalis A; Weaver M; Ribeiro RC
    Lancet Oncol; 2011 Aug; 12(8):719-20. PubMed ID: 21719348
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.
    Williams S; Chiong E; Lojanapiwat B; Umbas R; Akaza H;
    Lancet Oncol; 2013 Nov; 14(12):e524-34. PubMed ID: 24176571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?
    Akaza H
    Jpn J Clin Oncol; 2016 Apr; 46(4):299-302. PubMed ID: 26830151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Patient Navigation Leadership Summit (NPNLS): measuring the impact and potential of patient navigation.
    Cancer; 2011 Aug; 117(15 Suppl):i-ii. PubMed ID: 21780086
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.
    Chiong E; Tay MH; Tan MH; Kumar S; Sim HG; Teh BT; Umbas R; Chau NM
    Lancet Oncol; 2012 Nov; 13(11):e482-91. PubMed ID: 23117003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical practice guidelines for the adverse events in medical oncology].
    Isobe T; Hayashi M; Tsubata Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
    [No Abstract]   [Full Text] [Related]  

  • 14. Research agenda consensus conference.
    Lim HW; Resneck JS; Fischoff R
    J Am Acad Dermatol; 2013 Aug; 69(2):294. PubMed ID: 23643342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of guidelines in oncology].
    Hölzel D; Engel J; Schmidt M
    Z Arztl Fortbild Qualitatssich; 1999 Jan; 93(1):15-22. PubMed ID: 10198973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology].
    Fervers B; Bey P; Maigne D; Philip T
    Bull Cancer; 2001 Jun; 88(6):601-4. PubMed ID: 11459707
    [No Abstract]   [Full Text] [Related]  

  • 17. European cooperation for clinical practice guidelines in cancer.
    Philip T; Fervers B; Haugh M; Otter R; Browman G
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S1-3. PubMed ID: 12915895
    [No Abstract]   [Full Text] [Related]  

  • 18. The NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care.
    Carlson RW
    J Natl Compr Canc Netw; 2018 May; 16(5S):575-576. PubMed ID: 29784733
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.
    Vincent S; Djulbegovic B
    Cancer Treat Rev; 2005 Jun; 31(4):319-22. PubMed ID: 16006047
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of medical-decision making and the use of standards of care in oncology.
    Holzer S; Fremgen AM; Hundahl SA; Dudeck J
    Proc AMIA Symp; 2000; ():364-8. PubMed ID: 11079906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.